In August 2022, the American Heart Association released a statement outlining new recommended guidelines for managing infective endocarditis in people who inject drugs, providing a timely and comprehensive approach to the management of the disease than what was previously provided by the AHA. With the incidences of infective endocarditis cases among people who inject drugs is on the rise nationally, the AHA realized the need for a review of their existing statement to accommodate the unique features of the disease in this population. So, in 2021, the AHA convened a writing group of nationally recognized experts, including Laura Marks, MD, PhD, assistant professor of medicine, Washington University School of Medicine, Division of Infectious Diseases. Marks specializes in clinical infectious diseases with a special focus on infectious complications in people who inject drugs.
Laura Marks, MD, PhD (PSTP Alumni), contributes to American Heart Association statement on injective drug use infective endocarditis
View Content